These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20088924)

  • 1. ADAMTS-13 assays in thrombotic thrombocytopenic purpura.
    Peyvandi F; Palla R; Lotta LA; Mackie I; Scully MA; Machin SJ
    J Thromb Haemost; 2010 Apr; 8(4):631-40. PubMed ID: 20088924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantages and limits of ADAMTS13 testing in the prognostic assessment of thrombotic thrombocytopenic purpura.
    Mannucci PM; Franchini M
    Presse Med; 2012 Mar; 41(3 Pt 2):e157-62. PubMed ID: 22244722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TTP and ADAMTS13: When Is Testing Appropriate?
    Mannucci PM; Peyvandi F
    Hematology Am Soc Hematol Educ Program; 2007; ():121-6. PubMed ID: 18024619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura.
    Bettoni G; Palla R; Valsecchi C; Consonni D; Lotta LA; Trisolini SM; Mancini I; Musallam KM; Rosendaal FR; Peyvandi F
    J Thromb Haemost; 2012 Aug; 10(8):1556-65. PubMed ID: 22672482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency.
    George JN; Chen Q; Deford CC; Al-Nouri Z
    J Clin Apher; 2012; 27(6):302-11. PubMed ID: 22927184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study.
    Lancellotti S; Peyvandi F; Pagliari MT; Cairo A; Abdel-Azeim S; Chermak E; Lazzareschi I; Mastrangelo S; Cavallo L; Oliva R; De Cristofaro R
    Thromb Haemost; 2016 Jan; 115(1):51-62. PubMed ID: 26272487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency.
    Tsai HM
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):609-32, v. PubMed ID: 17666281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura.
    Zheng XL
    J Thromb Haemost; 2024 May; 22(5):1358-1365. PubMed ID: 38360215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New marker in thrombotic thrombocytopenic purpura].
    Gøtze JP; Hillarp A; Lindblom A; Björk P; Strandberg K; Nielsen LB
    Ugeskr Laeger; 2008 Aug; 170(33):2446-9. PubMed ID: 18761827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
    Starke R; Machin S; Scully M; Purdy G; Mackie I
    Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura: a moving target.
    Sadler JE
    Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.
    Camilleri RS; Cohen H; Mackie IJ; Scully M; Starke RD; Crawley JT; Lane DA; Machin SJ
    J Thromb Haemost; 2008 Feb; 6(2):331-8. PubMed ID: 18031293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children.
    Loirat C; Girma JP; Desconclois C; Coppo P; Veyradier A
    Pediatr Nephrol; 2009 Jan; 24(1):19-29. PubMed ID: 18574602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura in children.
    Loirat C; Coppo P; Veyradier A
    Curr Opin Pediatr; 2013 Apr; 25(2):216-24. PubMed ID: 23422353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura in childhood: an uncommon but life-threatening cause of thrombocytopenia.
    Davis A; Barnes C
    J Paediatr Child Health; 2007 Sep; 43(9):640-2. PubMed ID: 17688649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombotic-thrombocytopenic purpura].
    Hellmann M; Hallek M; Scharrer I
    Internist (Berl); 2010 Sep; 51(9):1136, 1138-44. PubMed ID: 20689903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.